Functional Gastrointestinal Disorders
Functional Gastrointestinal Disorders (FGID), also known as disorders of gut-brain interaction, encompass various idiopathic conditions that affect different parts of the gastrointestinal tract, characterized by persistent and recurring symptoms like diarrhea or constipation due to visceral hypersensitivity and motility disturbances. The most common of these disorders is irritable bowel syndrome (IBS).
Health Outcomes
- Accurate Enumeration of Viable Probiotic Bacteria
- Achieved Clean Fecal Loading
- Alleviated Constipation
- Alleviated Constipation Symptoms
- Altered Gastrointestinal Microbiome Composition
- Altered Intestinal Transit
- Confirmed Safety of Oral Probiotic Administration
- Enhanced Functional Gut Microbial Pathways
- Enhanced Gastric Viability
- Enhanced Gastrointestinal Stress Resistance
- Enhanced Probiotic Gut Adhesion
- Enhanced Vagal Nerve Activity in the Stomach
- Exercise-Induced Gastrointestinal Symptoms
- Gastrointestinal Tract Persistence
- Improved 2'-Fucosyllactose Degradation
- Improved Abdominal Pain Frequency
- Improved Bifidogenic Response
- Improved Bloating
- Improved Bloating Symptoms
- Improved Bowel Function Index
- Improved Bowel Habits
- Improved Bristol Stool Score
- Improved Chronic Constipation
- Improved Composite Score of Irritable Bowel Syndrome Symptoms
- Improved Constipation
- Improved Constipation Relief
- Improved Digestive Comfort
- Improved Digestive Efficiency
- Improved Digestive Health
- Improved Digestive Viability
- Improved Functional Constipation
- Improved Functional Diarrhea Symptoms
- Improved Functional Dyspepsia Symptoms
- Improved Functional Genes in Intestinal Microbiota
- Improved Gastric Emptying Time
- Improved Gastric Tolerance
- Improved Gastrointestinal Discomfort
- Improved Gastrointestinal Function
- Improved Gastrointestinal Health
- Improved Gastrointestinal Peristalsis
- Improved Gastrointestinal Recovery
- Improved Gastrointestinal Resilience
- Improved Gastrointestinal Resistance
- Improved Gastrointestinal Score
- Improved Gastrointestinal Symptom Management
- Improved Gastrointestinal Symptom Rating Scale Score
- Improved Gastrointestinal Symptom Relief
- Improved Gastrointestinal Symptom Score
- Improved Gastrointestinal Transit
- Improved Gastrointestinal Viability
- Improved Gastrointestinal Well-Being
- Improved General IBS Symptoms
- Improved Gut Comfort
- Improved Gut Microbiome Composition
- Improved Gut Microbiome Function
- Improved Gut Microbiota Distribution
- Improved Gut Motility
- Improved Gut Stress Resistance
- Improved Gut Tolerance
- Improved Gut-Brain Axis Function
- Improved Gut-Brain Axis Homeostasis
- Improved Host-Probiotic Interaction
- Improved IBS Severity
- Improved Incomplete Defecation
- Improved Indigestion Symptoms
- Improved Intestinal Motility
- Improved Intestinal Transit
- Improved Irritable Bowel Syndrome Symptom Severity
- Improved Irritable Bowel Syndrome Symptoms
- Improved Irritable Bowel Syndrome Symptoms in Adults
- Improved Overall Gastric Symptoms
- Improved Overall Gastrointestinal Symptoms
- Improved PAC-QoL Score
- Improved Probiotic Product Stability
- Improved Progressive Motility
- Improved Symptoms of Functional Bowel Disorders
- Improved Transit Time
- Increased Bloating
- Increased Endogenous Bifidobacteria Levels
- Increased Faecal Serotonin Levels
- Increased Fecal Lactic Acid Bacteria Concentration
- Increased Fullness
- Increased Gastric Antral Length
- Increased Gastrointestinal Discomfort
- Increased Interest in Probiotic Supplements
- Increased Intestinal Motility
- Increased Prebiotic Fermentation Activity
- Increased Probiotic Bacterial Survival Through Upper Gastrointestinal Transit
- Increased Resistance to Simulated Gastrointestinal Conditions
- Increased Serum Motilin Levels
- Increased Short-Chain Fatty Acid-Producing Gut Flora
- Increased Tolerance to Gastrointestinal Conditions
- Maintained Digestive Function
- Maintained Gastrointestinal Health
- Maintenance of Therapeutic Probiotic Levels
- Moderate Changes in Gastrointestinal Bacterial Groups
- Moderate Impact on Main GI Bacterial Groups
- Modified Fecal Microbiota
- Modulated Gastrointestinal Microbiota
- Modulated Microbiota-Gut-Brain Axis
- Neutral Probiotic Delivery Through Digestion
- No Clinically Relevant Changes in Gastrointestinal Quality of Life
- No Demonstrated Efficacy for Isolated Bifidobacterium Use
- No Increase in Fecal Incontinence
- No Significant Change in Duration of Gastrointestinal Symptoms
- No Significant Change in Gastrointestinal or General Wellbeing
- No Significant Change in Gut Transit Time
- No Significant Improvement in Global Gastrointestinal Well-being
- No Worsening of Gastrointestinal Symptoms
- Potential Probiotic Health Effects
- Prevented Visceral Hyperalgesia
- Rapid Galactooligosaccharide Degradation During Gastrointestinal Transit
- Reduced Abdominal Cramping
- Reduced Abdominal Discomfort
- Reduced Abdominal Pain Intensity
- Reduced Bowel Discomfort Symptoms
- Reduced Burping Frequency
- Reduced Calprotectin Level
- Reduced Colonic Contraction Frequency
- Reduced Constipation Prevalence
- Reduced Constipation Severity
- Reduced Constipation Symptoms
- Reduced Constipation Symptoms in IBS
- Reduced Days with Defecation Urgency
- Reduced Defecation Frequency
- Reduced Epigastric Discomfort
- Reduced FGID Severity
- Reduced Feeding Intolerance
- Reduced Frequency of Functional Gastrointestinal Symptoms
- Reduced Functional Dyspepsia Symptoms
- Reduced Functional Gastrointestinal Symptom Frequency
- Reduced Gastric Emptying Time
- Reduced Gastric Symptoms
- Reduced Gastrointestinal Adverse Events
- Reduced Gastrointestinal Discomfort Symptoms
- Reduced Gastrointestinal Disorder Symptoms
- Reduced Gastrointestinal Symptom
- Reduced Gastrointestinal Symptom Rating Scale Score
- Reduced Gastrointestinal Symptom Severity
- Reduced Gastrointestinal Symptoms
- Reduced Gastrointestinal Symptoms Score
- Reduced Gut Disorders
- Reduced Hard Stool
- Reduced IBS Symptoms
- Reduced Infant Colics
- Reduced PAC-SYM Score
- Reduced Postprandial Acidification
- Reduced Postprandial Discomfort
- Reduced Postprandial Fullness
- Reduced Pyloric Pressure
- Reduced Sensation of Incomplete Evacuation
- Reduced Stress-Induced Gastrointestinal Symptoms
- Reduced Time Spent for Defecation
- Reduced Visceral Hypersensitivity
- Reduced Whole Gut Contraction Frequency
- Regulated Gastrointestinal Function
- Relieved Gastrointestinal Symptoms
- Stable Bowel Function
- Unchanged Colonic Transit Time
- Unchanged Gastrointestinal Resistance
- Unchanged Gastrointestinal Symptoms
- Unchanged Stool Consistency or Bowel Frequency